The holidays are upon us and this year we would like to share with you some of the most elevated deals happening in the cannabis space! Whether you are looking for skin care products, hemp flower, or cannabis accessories, we have you covered! Check out the growing list of cannaContinue Reading

“In light of the current state of COVID-19 and the CDC’s actions, Americans for Safe Access has been monitoring the situation to make sure that medical cannabis patients are not forgotten,” said ASA Founder and President Steph Sherer. We want to ensure that dispensaries are seen as essential businesses that will remain open for patients. We applaud states that have already put emergency precautions into action and we will keep patients and the public updated on any future developments through our response page.”Continue Reading

PRESS RELEASE – IMMEDIATE RELEASE Chester Springs, Pennsylvania –(BUSINESS WIRE)—Affinity Bio Partners, LLC,  a global clinical research organization focused on Medical Cannabis and CBD Clinical Research, Affinity Patient Advocacy, LLC, a non-profit patient advocacy firm and AI Health Outcomes, LLC, an Artificial Intelligence Technology company which is the parent companyContinue Reading

” Privy Peach, a women-centric CBD brand based out of Colorado, is excited to announce the re-release of their highly sought after intimate oil with increased CBD content just in time for Valentine’s Day. The Privy Peach intimate oil is now available with 50 mg more of CBD for a total of 300mg for the same price of the previous offering (12 pouches instead of 10).”Continue Reading

FOR IMMEDIATE RELEASE PITTSBURGH PENNSYLVANIA, UNITED STATES – January 15th, 2020 Compassionate Certification Centers™, a medical cannabis healthcare system, in collaboration with Affinity Bio Partners, a Clinical Research Organization (CRO), and AI Health Outcomes, CannaBot™, are pleased to announce the conclusion and publication of a medical marijuana-focused observational study in Pennsylvania. ThisContinue Reading

Affinity Bio Partners, AI Health Outcomes and CannaBot will work together to manage research and development projects, clinical studies, assist with patient education, utilization of artificial technology through the CannaBot™ for ARK’s Research and Development efforts within South Africa as well as ARK’s entrance into the United States market. Continue Reading